100 Abbott Park Road
United States - Map
Abbott Laboratories manufactures and sells health care products worldwide. The companys Established Pharmaceutical Products segment offers branded generic pharmaceuticals to treat pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptoms; gynecological disorders; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Ménière's disease and vestibular vertigo; pain, fever, and inflammation; migraines; anti-infective clarithromycin; and influenza vaccines, as well as to regulate physiological rhythm of the colon. Its Diagnostic Products segment provides immunoassay and clinical chemistry systems; assays used to screen and/or diagnosis cancer, cardiac, drugs of abuse, fertility, infectious diseases, and therapeutic drug monitoring; hematology systems and reagents; diagnostic systems and cartridges; instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents; genomic-based tests; informatics and automation solutions; and instrument used to identify infection-causing pathogens. The companys Nutritional Products segment provides pediatric and adult nutritional products, such as prepared infant and follow-on formulas. Its Vascular Products segment offers coronary, endovascular, vessel closure, and structural heart devices to treat vascular disease. The company also provides blood and flash glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes; and medical devices for the eye, such as cataract and LASIK surgery, contact lens care, and dry eye products. It serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. The company has strategic alliance with Fonterra. Abbott Laboratories was founded in 1888 and is headquartered in Abbott Park, Illinois.
|Abbott Laboratories’s ISS Governance QuickScore as of May 1, 2016 is 5. The pillar scores are Audit: 2; Board: 6; Shareholder Rights: 8; Compensation: 2.|
|Brought to you by Institutional Shareholder Services (ISS)|
|Mr. Miles D. White ,
Chairman of The Board, Chief Exec. Officer and Chairman of Exec. Committee
|Mr. Brian B. Yoor ,
Chief Financial Officer and Sr. VP of Fin.
|Mr. Thomas Craig Freyman ,
Exec. VP of Fin. & Admin.
|Dr. John M. Capek Ph.D.,
Exec. VP of Ventures
|Mr. Michael J. Warmuth ,
Exec. VP of Established Pharmaceuticals
|Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|